| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.5M | +162.6% |
| Cost of Revenue | $2.9M | +758.6% |
| R&D Expense | $39.8M | +102.9% |
| SG&A Expense | $34.3M | +128.2% |
| Operating Income | -$49.6M | -16.7% |
| Interest Expense | $1.5M | +348.1% |
| Pre-tax Income | -$46.0M | -8.8% |
| Income Tax | $0 | +100.0% |
| Net Income | -$46.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.0M | -34.2% |
| Accounts Receivable | $16.1M | +124.3% |
| Inventory | $9.8M | +1366.6% |
| Current Assets | $86.9M | -6.5% |
| Total Assets | $172.3M | +49.2% |
| Current Liabilities | $73.7M | +528.7% |
| Total Liabilities | $110.5M | +271.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | -79.2% |
| Capital Expenditures | $296K | +218.3% |
| Investing Cash Flow | -$17.4M | +52.6% |
| Financing Cash Flow | $28.5M | +240.8% |
| Free Cash Flow | -$33.8M | -79.9% |
| -10.8% |
| EPS (Basic) | -$1.30 | -8.3% |
| Stockholders' Equity |
| $61.9M |
| -27.9% |